CARRIE BALLENGER: Open Payments
NPI 1275175093 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,112 in 125 payments from 21 companies in 2025. Trend: 2023 $2,544 · 2024 $3,042 · 2025 $2,112
Food & beverage: $2,112
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 19 | $301 |
| ABBVIE INC. | 26 | $260 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $252 |
| Axsome Therapeutics, Inc. | 10 | $176 |
| Lundbeck LLC | 9 | $173 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $156 |
| Vanda Pharmaceuticals Inc. | 8 | $138 |
| Noven Therapeutics, LLC | 6 | $116 |
| Alkermes, Inc. | 3 | $75 |
| Tris Pharma Inc | 3 | $68 |
Products named: REXULTI, VRAYLAR, CAPLYTA, Auvelity, TRINTELLIX, HETLIOZ, Xelstrym, Dyanavel XR.
Industry payments across SC — which companies pay providers there.
